SREBF2 and neoplasm: DAXX’s SUMO-binding property is critical to the DAXX-SREBP2 interaction (Fig. 2), de novo lipogenesis (Fig. 3), DAXX’s recruitment to lipogenic genes (Fig. 4), and in vivo tumor growth (Fig. 5).